The Role of Cardiac Rehabilitation. The Role of Cardiac Rehabilitation. in Heart Failure. in Heart Failure. History of Cardiac Rehab.

Similar documents
Cardiac Rehabilitation for Heart Failure Patients. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System

HEART FAILURE AN OMINOUS DISEASE

Peripheral Contributions to HFpEF

The Role of Exercise in Management of Patients with Heart Failure

PHYSICAL AND SEXUAL ACTIVITIES

Rebuilding and Reinvigorating Cardiac Rehabilitation in 2018

Value of Cardiac Rehabilitation for Improving Patient Outcomes

Cardiac Rehabilitation Program for LVAD Patients. Dr Katherine Fan Consultant Cardiologist Grantham Hospital, Hong Kong SAR

High Intensity Interval Exercise Training in Cardiac Rehabilitation

Cardiac Rehabilitation Individualized Healing for Patients with Cardiovascular Disease

The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager

WHAT IS ADVANCED HEART FAILURE? James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

What is established? Risk of Benefit complica comp tion

Subject: Outpatient Phase Ii Cardiac Rehab Individualized Treatment Plan And Exercise Prescription

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Chronic Primary Mitral Regurgitation

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiac & Pulmonary Rehab Individual Treatment Plan

BACPR Annual Conference Generic versus Specialist Rehabilitation FOR

HFpEF: Pathophysiology & Treatment

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Diastolic Heart Failure Uri Elkayam, MD

Glenn Bean, M.S., FAACVPR

Biological Correlates of Frailty in Older Heart Failure Patients

Individual Cardiac Treatment Plan rev 1/10 Name: DOB: Age: Date entered program: Diagnosis: Date of event: Allergies:

Cardiac Rehabilitation Should be Paid in Korea?

HFpEF, Mito or Realidad?

Congestive Heart Failure: Outpatient Management

Cardiac rehabilitation: a beneficial effect in CHD?

Management of Heart Failure in Adult with Congenital Heart Disease

Therapeutic Targets and Interventions

The role of CPX testing in the rehabilitation of cardiac patients.

Updates in Congestive Heart Failure

How atrial fibrillation should be treated in the heart failure patient?

Heart Failure with Preserved Left Ventricular Ejection Fraction. (HFpEF)

L esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione. M. Guazzi

The right heart: the Cinderella of heart failure

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F.

Exercise Testing/Echocardiography in Asymptomatic AS

CPX and Prognosis in Cardiovascular Disease

Walking together: Palliative Care and heart failure.

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Dr.Fayez EL Shaer Consultant cardiologist Assistant professor of cardiology KKUH

Heart Failure Overview. Dr Chris K Y Wong

Atrial dysfunction and chronotropic incompetence

Get With The Guidelines: Lessons for National Healthcare Improvement Programs

Controversies in Cardiac Pharmacology

Atrial Fibrillation Ablation in Patients with Heart Failure

Steven S. Saliterman, MD, FACP

Decline in CV-Mortality

Preventive Cardiology

The Best Kept Secret in Your Medical Neighborhood. Evidence Based Cardiac and Pulmonary Rehabilitation

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Susan P. D Anna MSN, APRN BC February 14, 2019

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Value of cardiac rehabilitation Prof. Dr. L Vanhees

HFPEF Echo with Strain vs. MRI T1 Mapping

Acute Coronary Syndrome. Sonny Achtchi, DO

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Heart Failure patient and Cardiac Rehabilitation. Sonia CORONE

Heart Failure Guidelines For your Daily Practice

CARDIAC REHABILITATION

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher

Diabetes and the Heart

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT

The Role of ICD Therapy in Cardiac Resynchronization

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Heart Failure in Women

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Mobilization and Exercise Prescription

The life after myocardial infarction: a long quiet river?

The Art and Science of Pulmonary Rehab. Pam Haines, RCP Cardiopulmonary Rehab Manager

UPDATES IN MANAGEMENT OF HF

Diastolic Heart Failure (HFpEF) Felix J. Rogers, DO, FACOI April 29, 2018

Subject: Assessment of Functional Capacity Melanie Elliott-Eller RN MSN Lee Lipsenthal MD February 2011

Chapter 21 Training for Anaerobic and Aerobic Power

Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58

AACVPR/ACC/AHA PERFORMANCE MEASURES. Neil Oldridge, PHD, FAACVPR Ileana L. Piña, MD, FACC John Spertus, MD, MPH, FACC

Heart Failure with Preserved Ejection Fraction (HFpEF): Natural History and Contemporary Management

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

Strength and conditioning? Chapter 4 Training Techniques. Weight gain (24yr, 73kg, 177cm, takes 18% protein) Guidelines.

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Exercise Prescription for Patients with CHF

LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?

Exercise after CABG: The Good The Bad and the Ugly

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Planned Interventions

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Patient-Reported Outcomes: A Critical Insight into the Impact of Therapy

THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION

2018 Program Certification Are You Ready?

Individualizing and Expanding Care ( Perspectives for the VCN from )

Bi-Ventricular pacing after the most recent studies

Transcription:

The Role of Cardiac Rehabilitation The Role of Cardiac Rehabilitation in Heart Failure in Heart Failure Kate Traynor RN MS FAACVPR Financial Disclosures No relevant financial relationship exists. History of Cardiac Rehab Late 1700 s: Europe- first mention of exercise in heart disease.who set himself the task of sawing wood for ½ hr every day was 6 mos later nearly cured. Early 1990 s:initial positive attitude toward physical fitness was forgotten( Bedrest) 1940-1950s: Management slowly evolved from armchair to more gradual progression culminating with Dr. Paul Dudley White s treatment of Pres. Dwight D. Eisenhower Great Read 1

History Lesson (continued) 1960-1990s: Formal CR Programs (MGH 1979) developed as well as national (AACVPR) and local (MACVPR) CR organizations. Insurance and other regulatory influences came into play 2000-beyond: Focus on quality and outcomes for CR with institution of AACVPR program certification process, national outcome data registry, federal mandate for CR, and NQF endorsement of performance measures for referral to CR What is Cardiac Rehab? 10 Essential Core Components Patient Assessment Weight Management BP Management Lipid Management Diabetes Management Tobacco Cessation Psychosocial Assessment and Intervention Nutritional Counseling Exercise Evaluation/Training Physical Activity Counseling From 2001 ACC/AHA HF Practice Guidelines: Stages in the evolution of HF and recommended therapy by stage. Committee Members et al. Circulation 2001;104:2996-3007 Copyright American Heart Association 2

What s the Problem? Pathophysiological Mechanisms of Exercise Intolerance in Heart Failure Cardiac Systolic and/or diastolic dysfunction Reduced stroke volume Elevated filling pressures Secondary pulmonary hypertension and RV dysfunction Mitral regurgitation Reduced chronotropic reserve Ventilatory system Exaggerated minute ventilation relative to CO production Pulmonary hypertension and resulting pulmonary vascular damage and fibrosis Ventilation/perfusion mismatch Alveolar edema Skeletal muscle Reduced muscle mass Reduced Type IIa fibers relative to Type IIb fibers Reduced enzymes for oxidative metabolism and generation of ATP What s the benefit of Cardiac Rehab for HF patients? Exercise training in addition to psychosocial,risk factor management and /or educational interventions is considered Class I indication (useful and effective) in CAD pts with CAD Meta analysis of 71 trials ( n=13,824) demonstrated reduced all cause cardiac mortality, nonfatal reinfarction, reduced re hospitalization and significant positive changes in modifiable RF( TC,TG,BP) Oldridge et al, 2012, Future Cardiology Exercise training in individuals with HF had significant effect on improving functional capacity, oxygen consumption, 6 minute walk test distances, symptoms, self efficacy for exercise, and QOL Norman 2012,Journal of Geriatric Physical Therapy Benefits Cardiac Rehab Depression: gender differences in depressive symptoms of HF pts Men= financial status, functional capacity, perceived control and anxiety Women= BMI, perceived control and anxiety Eastwood et al 2012, Eur Jour CV Nsg Methods of improving self efficacy improve self care in HF population with multiple comorbidities Dickson et al 2013, Nsg Research 3

Benefits Cardiac Rehab TIME-CHF Trial- the patient's ability to estimate his own daily working capacity(dasi) seems to carry a higher prognostic value than that estimated from repeat functional exercise testing. Spruit et al 2012, JACC HF ACTION Randomized Control Trial Clearly established the efficacy and safety of exercise training in pts with chronic HF (reduced EF) Multicenter randomized control trial of 2331 outpts with HF Intervention: Usual care plus aerobic exercise training ( 36 supervised sessions followed by home care) vs. usual care alone Mean age 59, 28% F, 38% NYHA Class III or IV symptoms, 51% ischemic HF, median LVEF 25% Conclusions: Exercise training was associated with significant reductions for both all-cause mortality or hospitalization and CV mortality or HF hospitalization. O Connor et al 2009, JAMA HF ACTION: Improved Quality of Life (QOL) Significant improvement in overall QOL score ( KCCQ) as well as key subscales for health status including physical limitations, symptoms, and social limitations Flynn et al 2009,JAMA 4

What s the story with HFpEF? Few studies have examined benefit in the heart failure with preserved EF population 3 studies ( 2 randomized with blinding of outcomes and 1 multicenter) demonstrated endurance training can exercise capacity and symptoms but what s the mechanism?? Small study HFpEF: pts had reduced exercise capacity, distensibility and dynamic Starling mechanism pre training Results: After 1 yr, endurance exercise training failed to impart favorable effects on CV stiffness or function in HFpEF Fujimoto et al 2012, AHJ Central disappointment but peripheral promise! Improvements in peak VO2 due to either improvements in cardiac output( HRxSV) and/or arteriovenous difference (A-VO2 diff) CO= central CV response to exercise A-VO2 Diff= peripheral response and is determined by skeletal muscle perfusion Fujimoto s study suggested that improved skeletal muscle perfusion likely plays a major role in the adaptation to exercise training in HFpEF. HF Action Trial demonstrated that exercise training: A. Reduced all -cause mortality or hospitalization, CV mortality and HF hospitalization B. Isn t worth it C. Negatively impacts quality of life for HF pts D. Is much ado about nothing 5

Cardiac Rehab for HF patients 1. Assessment: H&P, comprehensive RF analysis, psychosocial and nutrition evals, and assessment ex capacity ( 6 min walk test may be as good prognostically as symptom limited ETT) 2. Individual Treatment Plan ( ITP): problem focused with specific goals( outcomes), plans (interventions/education) and evaluation/progress assessments every 30 days duration program Components: Knowledge( disease process and meds), Lipids, Blood Sugar Control, Smoking Cessation, Weight Management, Psychosocial Factors, Nutritional Considerations, and Activity/Exercise Training Considerations for HF pts Standard ex prescription is aerobic activity 30 min 5x or more per week with parameters for intensity (70-85% max attained HR on ETT), duration, frequency Approach: interval training vs. continuous Giannuzzi et al 2003, Circulation; Wisloff et al 2007,Circulation Modality: strength/resistance training shown benefits Beckers et al 2008, Eur Heart Jour Challenges and Opportunities Adherence Referral to CR Insurance (Medicare) 6

MGH Experience: HF pts in Cardiac Rehab 292 pts with diagnosis CM, LV Failure (only 10 pts had EF>50%) M W AvAge Age Range Av entry METs DM Grads(51%) 119 30 62 33-86 5.83 46 Dropout (49%) 111 31 58 25-88 5.93 51 MGH Experience smokers_ grade ICD BMI DASI lowpa(gms) highna Grads(149) 22 14 21 29 7 48 85 Dropouts(143) 32 13 21 31 6.7 34 78 Success! Graduates: completed average 24 sessions DASI 93% GMS: 66% PA and 53% NA LDL at goal: 26% improvement from entry HDL at goal : 50% improvement from entry Sub Max ex capacity: 56% ( METs) BP at goal: 85% from entry 7

Thank you! 8